BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30408026)

  • 21. CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity.
    Sang Y; Li Y; Zhang Y; Alvarez AA; Yu B; Zhang W; Hu B; Cheng SY; Feng H
    Nat Commun; 2019 Sep; 10(1):4013. PubMed ID: 31488827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircSMARCA5 Facilitates the Progression of Prostate Cancer Through miR-432/PDCD10 Axis.
    Dong C; Fan B; Ren Z; Liu B; Wang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):70-83. PubMed ID: 32407167
    [No Abstract]   [Full Text] [Related]  

  • 23. TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma.
    Liang J; Xing D; Li Z; Shen J; Zhao H; Li S
    Mol Med Rep; 2016 Jun; 13(6):5200-6. PubMed ID: 27121462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway.
    Liu G; Song J; Zhao Y; Zhang L; Qin J; Cui Y
    J Recept Signal Transduct Res; 2020 Oct; 40(5):471-478. PubMed ID: 32340525
    [No Abstract]   [Full Text] [Related]  

  • 25. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells.
    Wu W; Chen J; Wu J; Lin J; Yang S; Yu H
    Oncol Rep; 2017 Oct; 38(4):2480-2488. PubMed ID: 28849218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D; Wang JJ; Li JS; Xu QY
    Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis.
    Wang F; Wang H; Sun L; Niu C; Xu J
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C392-C401. PubMed ID: 32348176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma.
    Chen G; Chen W; Ye M; Tan W; Jia B
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30389710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
    Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM59 promotes osteosarcoma progression via activation of STAT3.
    Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
    Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
    Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
    J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
    Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB
    PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT/ERK signaling.
    Liu J; Wang J; Tian W; Xu Y; Li R; Zhao K; You C; Zhu Y; Bartsch JW; Niu H; Zhang H; Shu K; Lei T
    Aging (Albany NY); 2022 Aug; 14(15):6066-6080. PubMed ID: 35963638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
    Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
    J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1.
    Tian Y; Guo Y; Zhu P; Zhang D; Liu S; Tang M; Wang Y; Jin Z; Li D; Yan D; Li G; Zhu X
    Aging (Albany NY); 2019 Oct; 11(19):8623-8641. PubMed ID: 31600735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA‑26a‑5p and miR‑26b‑5p inhibit the proliferation of bladder cancer cells by regulating PDCD10.
    Wu K; Mu XY; Jiang JT; Tan MY; Wang RJ; Zhou WJ; Wang X; He YY; Li MQ; Liu ZH
    Oncol Rep; 2018 Dec; 40(6):3523-3532. PubMed ID: 30272373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer.
    Geng B; Liang M; Qin L; Zhao W; Wang H; Wang L; Pan X; Chen X
    J Cell Mol Med; 2019 Feb; 23(2):1458-1469. PubMed ID: 30515965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of tripartite motif 59 (TRIM59) inhibits tumor growth in prostate cancer.
    Lin WY; Wang H; Song X; Zhang SX; Zhou PS; Sun JM; Li JS
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4864-4873. PubMed ID: 27981550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.